pharmaceutical company
The FDA user fee reauthorization, and issues related to rare disease innovation including the HEART ACT (HR 7667) and the BENEFIT Act (HR4472).
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
AMRYT PHARMA
160 Federal Street, 21st floor, Boston, MA, 02110, US
LISA F NELSON